Pharmaceutical
May 21, 2007
Jeffrey Kindler, the chief executive of the world''s largest drug maker Pfizer Inc., continued to clean house with the announcement late Sunday that the company''s research and development chief and
Read More
April 17, 2007
A federal judge in New Jersey has dismissed a securities class action lawsuit brought against Merck & Co. by investors over its one-time blockbuster drug Vioxx because the statute of
Read More
April 9, 2007
According to Reuters, a U.S. federal court has ruled that a drug-coated stent sold by Johnson and Johnson does not infringe a patent held by Boston Scientific Corp. The patent
Read More
April 4, 2007
Britain''s government competition watchdog began an investigation into the supply of medicines across the country after Pfizer Inc. signed a deal to sell its prescription drugs through a single wholesaler,
Read More
March 27, 2007
Teva Pharmaceutical Industries Ltd., the world''s largest maker of generic drugs, said it plans to appeal a U.S. judge''s decision to uphold patents protecting Pfizer Inc.''s pain reliever Celebrex, the
Read More
March 19, 2007
The Associated Press reports that Pfizer Inc. chairman and CEO Jeffrey B. Kindler received compensation last year that the company valued at $11.4 million, according to a regulatory filing on
Read More
February 28, 2007
The Associated Press reports that attorneys for Mylan Laboratories Inc. have said the generic drug maker will appeal a ruling barring it from marketing a generic version of Pfizer Inc.''s
Read More
February 19, 2007
The Associated Press reports that drug maker Bristol-Myers Squibb Co. has purchased an 89-acre site to build a new plant for manufacturing biological compounds.The company said the new Devens, Mass.
Read More
February 6, 2007
The Associated Press reports that U.S. drug maker Pfizer Inc. recently lost a minor legal battle with Chinese rivals over rights to names for its popular anti-impotence drug Viagra, a
Read More
December 19, 2006
According to the Associated Press, Merck & Co. plans to invest about $100 million to expand its vaccine manufacturing facility in Durham if approved by county commissioners. The planned 115,000-square-foot
Read More